Loading clinical trials...
Loading clinical trials...
Prevention of Acute Myocardial Injury by Trimetazidine in Patients Hospitalized for Moderate to Severe Acute Respiratory Syndrome Caused by SARS-CoV-2
Conditions
Interventions
Trimetazidine
Locations
1
Brazil
Heart Institute (InCor-HCFMUSP)
São Paulo, São Paulo, Brazil
Start Date
December 10, 2020
Primary Completion Date
April 30, 2021
Completion Date
April 30, 2021
Last Updated
February 21, 2021
NCT05198791
NCT07450846
NCT07414056
NCT06701669
NCT07262541
NCT06474754
Lead Sponsor
Ministry of Health, Brazil
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions